Dr Chiara Pizzamiglio Dr Renae Stefanetti Professor Bobby McFarland Dr Naomi Thomas Professor Michael Hanna et al. | Optimizing rare disorder trials: A phase 1a/1b randomized study of KL1333 in adults with mitochondrial disease | 2025 |
|
Dr William Macken Dr Mahmoud Fassad Dr Fei Gao Krutik Patel Dr Ana Topf et al. | Neuromuscular disease genetics in under-represented populations: increasing data diversity | 2023 |
|
Dr Chiara Pizzamiglio Dr Rhys Thomas Professor Grainne Gorman Professor Bobby McFarland Professor Michael Hanna et al. | COVID-19-Related Outcomes in Primary Mitochondrial Diseases: An International Study | 2022 |
|
Dr Yi Ng Dr Nichola Lax Dr Alasdair Blain Dr Daniel Erskine Professor Mark Baker et al. | Forecasting stroke-like episodes and outcomes in mitochondrial disease | 2022 |
|
Professor Laurence Bindoff Professor Grainne Gorman Professor Bobby McFarland Dr Yi Ng Dr Robert Pitceathly et al. | Comment on “A severe linezolid-induced rhabdomyolysis and lactic acidosis in Leigh syndrome” | 2021 |
|
Professor Rita Horvath Dr Wei Wei Dr Robert Pitceathly Professor Michael Hanna Professor John Sayer et al. | Use of whole genome sequencing to determine genetic basis of suspected mitochondrial disorders: Cohort study | 2021 |
|
Professor Robert Taylor Professor Michael Hanna Dr Robert Pitceathly
| Multisystem mitochondrial disease caused by a rare m.10038G>A mitochondrial tRNAGly (MT-TG) variant | 2020 |
|
Dr Yi Ng Dr Mika Martikainen Professor Grainne Gorman Dr Alasdair Blain Dr Andrew Schaefer et al. | Pathogenic variants in MT-ATP6: A United Kingdom–based mitochondrial disease cohort study | 2019 |
|
Dr Charlotte Alston Dr Robert Pitceathly Professor Bobby McFarland Dr Andrew Schaefer Emeritus Professor Doug Turnbull et al. | The urinary proteome and metabonome differ from normal in adults with mitochondrial disease | 2015 |
|
Dr Robert Pitceathly Professor Bobby McFarland
| Mitochondrial myopathies in adults and children: management and therapy development | 2014 |
|
Professor Grainne Gorman Dr Robert Pitceathly Emeritus Professor Doug Turnbull Professor Robert Taylor
| RRM2B-Related Mitochondrial Disease | 2013 |
|
Dr Victoria Nesbitt Dr Robert Pitceathly Dr Simon Cockell Professor Michael Hanna Professor Patrick Chinnery et al. | The Medical Research Council Neuromuscular Centre for Translational Research Mitochondrial Disease Patient Cohort Study UK: From Conceptualisation to Utilisation | 2013 |
|
Dr Victoria Nesbitt Dr Robert Pitceathly Emeritus Professor Doug Turnbull Professor Robert Taylor Professor Bobby McFarland et al. | The UK MRC Mitochondrial Disease Patient Cohort Study: clinical phenotypes associated with the m.3243A>G mutation—implications for diagnosis and management | 2013 |
|
Dr Victoria Nesbitt Dr Robert Pitceathly Dr Simon Cockell Professor Michael Hanna Emeritus Professor Doug Turnbull et al. | The medical research council neuromuscular centre for translational research mitochondrial disease patient cohort study UK: from conceptualisation to utilisation | 2012 |
|
Dr Joanna Elson Dr John Yarham Professor Francois van der Westhuizen Dr Robert Pitceathly Professor Robert Taylor et al. | Towards a mtDNA locus-specific mutation database using the LOVD platform | 2012 |
|
Dr Victoria Nesbitt Dr Robert Pitceathly Professor Bobby McFarland Emeritus Professor Doug Turnbull
| A3243G - more than just MELAS! | 2011 |
|
Dr Charlotte Alston Dr Robert Pitceathly Professor Michael Hanna Dr Andrew Schaefer Professor Patrick Chinnery et al. | Dominant and recessive RRM2B mutations are frequent in familial PEO with multiple mtDNA deletions | 2011 |
|
Dr Victoria Nesbitt Dr Robert Pitceathly Emeritus Professor Doug Turnbull Professor Bobby McFarland
| The MRC Centre for Translational Research in Neuromuscular Disease: Mitochondrial Disease Patient Cohort Study UK | 2011 |
|
Dr Robert Pitceathly Dr Victoria Nesbitt Professor Bobby McFarland Emeritus Professor Doug Turnbull
| MRC mitochondrial cohort study: development of a UK database | 2010 |
|